Oleanolic acid (3β-hydroxyolean-12-en-28-oic acid, OA) is a pentacyclic triterpenes widely distributed in food, medicinal plants and nutritional supplements. OA exhibits various pharmacological properties, such as hepatoprotective and anti-tumor effects. In this study, we analyzed the effect of OA on endothelial dysfunction induced by high glucose in human vascular endothelial cells (ECs). Western blotting showed that OA attenuated high glucose-reduced nitric production oxide (NO) as well as . OA has received much attention, and is being marketed as therapeutic drug for the treatment of liver diseases, obesity associated insulin resistance, hypertension, atherosclerosis 4,5 . Especially, OA has been shown to possess promising anti-diabetic effects in various in vitro and in vivo models, as well as the ability to reduce blood pressure, blood glucose levels, total cholesterol, triglyceride, low density lipoprotein, and to increase the plasma insulin and high density lipoprotein levels 1, 6 . However, the signal pathways underlying these effects remain to be elucidated.
. OA has received much attention, and is being marketed as therapeutic drug for the treatment of liver diseases, obesity associated insulin resistance, hypertension, atherosclerosis 4, 5 . Especially, OA has been shown to possess promising anti-diabetic effects in various in vitro and in vivo models, as well as the ability to reduce blood pressure, blood glucose levels, total cholesterol, triglyceride, low density lipoprotein, and to increase the plasma insulin and high density lipoprotein levels 1, 6 . However, the signal pathways underlying these effects remain to be elucidated.
Substantial clinical and experimental evidence suggest that both diabetes and insulin resistance cause endothelial dysfunction, which is considered the earliest predictive factor for diabetes 7, 8 . One of the main targets against endothelial dysfunction is to improve endothelium-dependent vasodilatation. Nitric oxide (NO) is of critical importance as a mediator of vascular tone and blood pressure. Loss of NO bioavailability is a cardinal feature of endothelial dysfunction 9, 10 . Several factors contribute to loss of NO bioavailability in endothelial dysfunction states, including both reduced NO synthesis and NO scavenging by reactive oxygen species (ROS) 11 . In ECs, NO is produced by endothelial nitric oxide synthase (eNOS), which catalyzes the oxidation of L-arginine to produce NO. The activity of eNOS can be regulated by a number of post-translational modifications. Among them, protein kinase B (Akt) induces eNOS-Ser 1177 phosphorylation to modulate endothelial NO production in response to a wide variety of stimuli 12, 13 . PPARδ is a member of ligand-activated nuclear receptor transcription factors superfamily, which is ubiquitously expressed with high levels in placenta, skeletal muscles, and adipose tissue. PPARδ is also expressed in the vascular cells including ECs, smooth muscle cells and macrophages 14 . PPARδ plays important roles in various physiological vascular processes such as apoptosis, survival, angiogenesis and inflammation 15 . PPARδ also OA attenuated the high glucose-induced impairment of Akt-Ser 473 and eNOS-Ser 1177 phosphorylation. Phosphorylation of Akt at Ser 473 plays a critical role in the transduction of insulin signaling and, in turn, phosphorylates its downstream substrate eNOS at Ser 1177 to increase eNOS activity 13, 19 . In HUVECs, HG treatment suppressed the phosphorylation of both Akt-Ser 473 and eNOS-Ser
1177
. However, OA attenuated the suppression of Akt and eNOS phosphorylation by HG ( Fig. 2a and b) . As shown in Fig. 2c 
OA activated PPARδ in ECs.
We previously demonstrated a protective effect of PPARδ on endothelial function in diabetic mice through activating the Akt/eNOS signaling pathway 17 . Thus, we examined whether OA activated PPARδ in ECs. BAECs were transfected with the PPRE-driven luciferase reporter and PPARδ expression plasmid before exposed to OA. The reporter assay showed that OA increased the luciferase activity of PPARδ (Fig. 3a) . Further, we examined the effects of OA on the expressions of the endogenous PPARδ target genes including pyruvate dehydrogenase kinase 4 (PDK4), adipose differentiation-related protein (ADRP) and angiopoietin-like protein 4 (ANGPTL4). As shown in Fig. 3b , the mRNA expressions of PDK4, ADRP and ANGPTL4, were increased by OA. In addition, pretreatment with GSK0660, a selective antagonist of PPARδ , effectively abrogated the induction of PDK4, ADRP and ANGPTL4 by OA (Fig. 3c) , suggesting a PPARδ -specific mechanism.
OA attenuated the high glucose-induced impairment of NO production via PPARδ. In order to study whether PPARδ activity is required for the protective effect of OA on NO production against high glucose, HUVECs were pretreated with a selective PPARδ antagonist GSK0660 and then with OA (10 μ M, 12 h) before the exposure to high glucose. The results demonstrated that, in the presence of GSK0660, OA failed to restore the high glucose impaired NO production (Fig. 4a) . We further examined the role of PPARδ in the Akt and eNOS OA enhanced endothelium-dependent vasodilatation via PPARδ. Compared with the time-matched vehicle control, OA elicited concentration-dependent relaxations pre-contracted by KCl or phenylephrine in the rat arterial segments ( Fig. 5a and b) . Next, aortic rings were exposed to high glucose co-incubated with or without OA for 12 h. Acetylcholine-induced endothelium-dependent vasorelaxation was impaired by high glucose (Fig. 5c ). HG impaired blood vessel relaxation was attenuated by OA. However, the effect of OA was abolished when the arteries were pre-incubation with GSK0660 ( Fig. 5d ). These results suggest that OA improves endothelial relaxation and attenuates the high glucose impairment via the PPARδ activation.
Discussion
In this study, we have demonstrated for the first time that OA, as a natural product, can ameliorate the high glucose-triggered endothelial function by activating the nuclear receptor PPARδ . Previous studies showed that pentacyclic triterpenes from fruits and plants could increase estrogen receptor activities 20 and synthetic triterpenes has been identified as ligands for the PPARγ 21 . In addition, reporter gene assays showed that oleanolic acid increased PPARα activity in spontaneously transformed keratinocyte cell line HaCaT and CV-1 cells 22 . Punica granatum flower (PGF) and its component oleanolic acid enhanced the PPARα reporter activity in human embryonic kidney 293 cells, and this effect was completely suppressed by a selective PPARα antagonist 23, 24 . We and others have previously demonstrated that synthetic PPARδ agonists such as GW501516 and GW0742 could ameliorate a number of pathological features associated with diabetes and metabolic syndrome. In ECs, these agonists inhibited the expression of pro-inflammatory genes 14 . In mouse models for atherosclerosis, synthetic agonists of PPARδ reduced atherosclerotic lesions 25 . In obese diabetic mice, the PPARδ agonists prevented fatty liver by repressing sterol regulatory element binding protein-1 (SREBP1) and improved vascular function 17, 26 . These results clearly indicate that PPARδ is a promising target for treating metabolic syndrome and related cardiovascular diseases. However, clinical uses of such potent synthetic agonists have been seriously hindered largely due to the claimed cardiovascular adverse effects of PPARγ 27 . Therefore, searching natural compounds with PPARδ modulating properties and, in particular, vascular protective activity, represent a promising approach for metabolic syndrome and related vascular disorder, also in view of their advantageous effects in endothelial system and obesity prevention 28 . Emerging evidence revealed the beneficial effects of OA on endothelial function in vascular disorders associated to metabolic diseases. OA induced vasodilatation in isolated aortas from both normotensive and spontaneously hypertensive rats 5, 29 . NO was involved in the vasodilator responses of OA, and in ECs, OA induced phosphorylation of eNOS-Ser 1177 to increase NO production 30 . Further studies have shown that OA increased the phosphorylation of Akt-Ser 473 and led to eNOS activation 31 . These observations were largely consistent with our results. However, the mechanisms by which OA regulates Akt/eNOS pathway were poorly understood. Herein, we demonstrated that OA exerts the endothelial protective effects mainly by PPARδ activation. This notion was supported by its capacity of activating the PPAR-reporter (Fig. 3a) and the induction of multiple endogenous PPARδ target genes, PDK4, ANGPL4 and ADRP (Fig. 3b) . More importantly, the effects of OA were attenuated by a selective PPARδ antagonist GSK0660 (Fig. 3c) . It remains to be examined whether this pentacyclic triterpenoid serves as a bona fide ligand for PPARδ or enhances the transcriptional activity of PPARδ by a post-translational modification.
It is well known that exposure to high glucose impairs endothelial functions and decreases the NO production. These deleterious effects are attributed to the inhibition of expression and/or activity of eNOS 32, 33 . PPARδ agonists could ameliorate the endothelium-dependent vasodilatation impaired by HG via activating PI3K/Akt/ eNOS pathway in MAECs 17 . In the present study, we found that OA protected endothelial cells from high glucose injury (Fig. 1) . This effect could also be inhibited by blocking PPARδ (Fig. 2) . In endothelium-specific PPARδ deficient mice, both endothelium-dependent relaxations to ACh and endothelium independent relaxations to the NO donor were significantly impaired in the arteries, accompanied by decreased eNOS-Ser 1177 phosphorylation 34 . It is suggested that OA restores HG-impaired endothelial function by a PPARδ -mediated activation of Akt/eNOS signaling pathways. It is worth noting that OA and PPARδ both possess an anti-oxidative property 35 . Under oxidative stress, eNOS undergoes uncoupling and produces superoxide rather than NO. GTP cyclohydrolase I (GTPCH I), a rate-limiting enzyme responsible for tetrahydrobiopterin (BH4) de novo synthesis, switches eNOS from uncoupled to coupled state to balance the NO and reactive oxygen species (ROS) generations 36 . GTPCH I protein level was up-regulated by GW501516, as well as the production of BH4 in endothelial progenitor cells 37 . Thus, the effects of OA on GTPCH I expression and eNOS coupling remain to be investigated.
In summary, this study provided evidence that OA, a component of pentacyclic triterpenes, is a natural modulator of PPARδ and ameliorates the high glucose impaired endothelial dysfunction. It is suggested that OA has a potential application in the treatment of diabetes related vascular diseases.
Materials and Methods
Ethics statement. The animal experiment was approved by the institutional review board of Xi'an Jiaotong University and performed in accordance with the institutional and national guidelines for the care and use of animals.
Reagents. OA Cell culture. Human umbilical vein endothelial cells (HUVECs) were cultured in medium 199 containing heparin (0.1 mg/ml), acidic fibroblast growth factor (FGF) (10 ng/ml), L-glutamine (2 mM), penicillin (100 U/ml), streptomycin (100 U/ml) and 20% FBS. Bovine aortic endothelial cells (BAECs) were maintained in Dulbecco's modified Eagle medium (DMEM) with 10% FBS, penicillin (100 U/ml), streptomycin (100 U/ml).
MTT Assay for Cell Viability. Cell viability was evaluated by MTT assay. HUVECs and BAECs were seeded in 96-well plates and cultured until 80% confluence. Then the cells were treated with the indicated concentrations of OA for 24 h before incubation with 5 mg/ml MTT at 37 °C in 5% CO 2 atmosphere for 4 h. Next, the culture medium was removed and the formazan formed in the reaction was dissolved in 150 μ l DMSO. Cell viability was presented as a percentage of the vehicle.
Quantitative Reverse Transcriptase-PCR (qRT-PCR).
Total RNA was isolated using TRIzol Table 1 . Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an internal control. Western blotting. Cellular proteins were extracted with lysis buffer (50 mM Tris-HCl, pH 7.5, 15 mM EGTA, 100 mM NaCl, 0.1% Triton X-100 and the protease inhibitors Plasmids, Transfection and Reporter Assay. The plasmids expressing PPARδ and PPRE-TK-luciferase reporter contains 3 copies of PPAR-response elements (PPRE) from the acyl-coenzyme A (CoA) oxidase gene were transfected into subconfluent BAECs together with pRSV-gal, a plasmid expressing β -galactosidase by using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). 24 hours later, the cells were treated with or without OA. Cell lysates were harvested to measure the luciferase and β -gal activities.
Detection of NO. NO release was measured with using DAF-FM diacetate. Briefly, BAECs seeded on glass coverslips and treated with different stimuli. By the end of treatment, the cells were incubated with DMEM containing DAF-FM (5 μ M) for 30 min in the dark at 37 °C and then washed with PBS. Images were obtained using fluorescence microscopy (Olympus America Inc., NY, USA).
Vascular reactivity. Aortic rings (3 mm) were dissected from Sprague-Dawley rats and incubated with different treatments at 37 °C in 5% CO 2 , then mounted in Multi Myograph System (Danish Myo Technology A/S, Denmark) to measure the isometric force. During the whole experiment, the solution was continuously oxygenated with a gas mixture of 95% O 2 plus 5% CO 2 . To determine the vasodilatory effect of OA, KCl (60 mM) or phenylephrine (Phe, 10 μ M) was used to constrict arterial rings in advance. After sustained contraction was obtained, the concentration-dependent responses of OA (0.01-100 μ M) were examined. In order to evaluate the role of high glucose, arterial rings were incubated in medium containing 30 mM glucose in the presence or absence of 10 μ M OA to examine the acetylcholine-induced vasodilation.
Statistical analysis. Quantitative data are expressed as mean ± SEM. Student's t test and ANOVA were used to analyze the statistical significance for the differences between two or among more groups, respectively. The dose response curves were analyzed by using two-way ANOVA followed by Bonferroni post-tests. P < 0.05 was considered significant. Non-quantitative results were representative of at least three independent experiments.
